TCL Archive In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications July 2, 1982
TCL Archive NCAB Members Skeptical On NCI Reorganization; King Has “Alterative;” Terry T Head Centers January 27, 1978
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive NCI Cancer Bulletin publicized board’s resignation over liability concerns. April 16, 2004
